Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
S A Wells, M A Skinner


Since the discovery that germ-line mutations in the RET protooncogene are responsible for the multiple endocrine neoplasia (MEN) syndromes types 2A and 2B, prophylactic thyroidectomy has been recommended for MEN patients to prevent medullary thyroid carcinoma (MTC). In this report, we present the medium-term follow up results on the earliest group of 18 patients having prophylactic thyroidectomy for MEN 2A. There were no operative complications. Microscopic or grossly evident MTC was present in 14 (78%) of the resected patients. None of the patients had metastasis of their MTC to regional lymph nodes. At three years' follow up, there is no evidence of residual or recurrent MTC, based on biochemical testing. We conclude that prophylactic thyroidectomy, based on direct DNA testing for RET gene mutations, is an effective and safe way to manage MTC in patients with MEN 2A.


Dec 12, 2003·Surgery·Patricia Niccoli-SireUNKNOWN Groupe D'étude Des Tumeurs Endocrines
Feb 14, 2003·Lancet·Steven I Sherman
Nov 20, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A BoérO Esik
May 18, 2001·Surgical Oncology·N C Lee, J A Norton
Nov 20, 2002·Journal of the American College of Surgeons·Francisco J PomaresFrancisco J Tébar
Dec 6, 2002·The New England Journal of Medicine·Wylie Burke
Sep 23, 2003·Annals of Surgery·Murray F Brennan
Apr 28, 2001·BMJ : British Medical Journal·J P EvansW Burke
Jan 1, 2006·Hereditary Cancer in Clinical Practice·Jan Willem de GrootJohn Tm Plukker
Dec 24, 2005·Journal of Endocrinological Investigation·M F ErdoganG Erdogan
Aug 2, 2001·Seminars in Pediatric Surgery·M A Skinner
Feb 24, 2001·Australian and New Zealand Journal of Medicine·D L LearoydB G Robinson
Aug 29, 2003·Current Treatment Options in Oncology·Jeffrey F Moley
Sep 8, 2010·Current Problems in Surgery·Ismail JatoiMichael A Choti
Jan 20, 2005·Surgery·Frank J QuayleJeffrey F Moley
Jul 22, 2006·Surgery·Priscilla F McAuliffe, William G Cance
May 26, 2004·Clinics in Laboratory Medicine·Nicole Massoll, Ernest L Mazzaferri
Apr 25, 2008·Molecular Genetics and Metabolism·Catherine E Lewis, Michael W Yeh
Apr 25, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·T KahramanJ Th M Plukker
Jan 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monica M Bertagnolli
Jul 3, 2002·Nature Reviews. Genetics·Wylie Burke, Jon Emery
Mar 20, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Stacy K CarmichaelDesmond A Schatz
Jul 23, 2004·Acta Oto-laryngologica·Erik G CohenAlfio Ferlito
Feb 19, 2005·Journal of Surgical Oncology·Frank J Quayle, Jeffrey F Moley
Sep 28, 2006·Annals of the Royal College of Surgeons of England·Mahir Al-Rawi, Malcolm H Wheeler
Jan 1, 2014·Expert Review of Endocrinology & Metabolism·Theodora Pappa, Maria Alevizaki
Mar 1, 2007·Expert Review of Endocrinology & Metabolism·Malcolm H Wheeler
May 21, 2003·Journal of Internal Medicine·M S Cohen, J F Moley
Jul 20, 2006·Endocrine Reviews·Jan Willem B de GrootRobert M W Hofstra
Dec 15, 2018·Head & Neck·Katerina SaltikiMaria Alevizaki
Apr 12, 2003·Langenbeck's Archives of Surgery·Andrea FrillingChristoph Erich Broelsch
Jun 15, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth FoxFrank M Balis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.